Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb 10;11(3):201-14.
doi: 10.1038/nrd3651.

Cancer Biomarkers: Selecting the Right Drug for the Right Patient

Affiliations
Review

Cancer Biomarkers: Selecting the Right Drug for the Right Patient

Gary J Kelloff et al. Nat Rev Drug Discov. .

Abstract

This Perspective highlights biomarkers that are expressed as a consequence of cancer development and progression. We focus on those biomarkers that are most relevant for identifying patients who are likely to respond to a given therapy, as well as those biomarkers that are most effective for measuring patient response to therapy. These two measures are necessary for selecting the right drug for the right patient, regardless of whether the setting is in drug development or in the post-approval use of the drug for patients with cancer. We also discuss the innovative designs of clinical trials and methodologies that are used to validate and qualify biomarkers for use in specific contexts. Furthermore, we look ahead to the promises and challenges in the field of cancer biomarkers.

Similar articles

  • Strategies in functional proteomics: Unveiling the pathways to precision oncology.
    Favicchio R, Thepaut C, Zhang H, Arends R, Stebbing J, Giamas G. Favicchio R, et al. Cancer Lett. 2016 Nov 1;382(1):86-94. doi: 10.1016/j.canlet.2016.01.049. Epub 2016 Feb 2. Cancer Lett. 2016. PMID: 26850375 Review.
  • Biomarker strategy in lung cancer.
    Esencay M, Watson A, Mukherjee K, Hanicq D, Gubernick SI. Esencay M, et al. Nat Rev Drug Discov. 2018 Jan;17(1):13-14. doi: 10.1038/nrd.2017.166. Epub 2017 Sep 29. Nat Rev Drug Discov. 2018. PMID: 28959953 No abstract available.
  • Steps forward for cancer precision medicine.
    Salgado R, Moore H, Martens JWM, Lively T, Malik S, McDermott U, Michiels S, Moscow JA, Tejpar S, McKee T, Lacombe D; IBCD-Faculty. Salgado R, et al. Nat Rev Drug Discov. 2018 Jan;17(1):1-2. doi: 10.1038/nrd.2017.218. Epub 2017 Nov 24. Nat Rev Drug Discov. 2018. PMID: 29170471
  • Targeted therapy in cancer.
    Tsimberidou AM. Tsimberidou AM. Cancer Chemother Pharmacol. 2015 Dec;76(6):1113-32. doi: 10.1007/s00280-015-2861-1. Epub 2015 Sep 21. Cancer Chemother Pharmacol. 2015. PMID: 26391154 Free PMC article. Review.
  • Challenges with biomarkers in cancer drug discovery and development.
    Ileana Dumbrava E, Meric-Bernstam F, Yap TA. Ileana Dumbrava E, et al. Expert Opin Drug Discov. 2018 Aug;13(8):685-690. doi: 10.1080/17460441.2018.1479740. Epub 2018 May 24. Expert Opin Drug Discov. 2018. PMID: 29792354 No abstract available.
See all similar articles

Cited by 78 articles

See all "Cited by" articles

References

    1. Drugs. 2007;67(8):1125-38 - PubMed
    1. Nat Rev Clin Oncol. 2011 Nov 08;9(4):199-207 - PubMed
    1. Nat Rev Cancer. 2006 Dec;6(12):924-35 - PubMed
    1. Clin Cancer Res. 2005 Apr 15;11(8):2785-808 - PubMed
    1. Clin Cancer Res. 2006 Jun 15;12(12):3661-97 - PubMed

LinkOut - more resources

Feedback